Lobe Sciences Ltd. (LOBEF)
OTCMKTS · Delayed Price · Currency is USD
0.0300
-0.0036 (-10.58%)
Aug 6, 2025, 3:53 PM EDT
Lobe Sciences Market Cap
Lobe Sciences has a market cap or net worth of $6.33 million as of August 6, 2025. Its market cap has increased by 437.57% in one year.
Market Cap
6.33M
Enterprise Value
8.25M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since June 7, 2019, Lobe Sciences's market cap has decreased from 13.11M to 6.33M, a decrease of -51.74%. That is a compound annual growth rate of -11.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 6.33M | 98.68% |
| Dec 31, 2024 | 3.18M | 112.53% |
| Dec 29, 2023 | 1.50M | -33.91% |
| Dec 30, 2022 | 2.27M | -57.44% |
| Dec 31, 2021 | 5.33M | -73.34% |
| Dec 31, 2020 | 19.98M | 339.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 519.96M |
| Glass House Brands | 438.99M |
| American Oncology Network | 408.39M |
| Northwest Biotherapeutics | 376.73M |